Today is Saturday, Sep. 19, 2020

Department of Internal Medicine

Immunology, Allergy and Rheumatology

Photo of  John Beary III, MD

John Beary III, MD

  • Master's Degree: Georgetown University
  • Medical Degree: Harvard Medical School
  • Internship: Johns Hopkins Hospital
  • Residency : Johns Hopkins Hospital
  • Fellowship: Rheumatology Hospital for Special Surgery
Contact Information
  • Health Professions Building
  • 3255 Eden Avenue
  • Suite 350
  • Cincinnati, Ohio 45267-0563
  • Office 513-558-4701
  • Fax 513-558-3799
  • Email

Peer Reviewed Publications

Katyal, Nakul; George, Pravin; Nattanamai, Premkumar; Raber, Larry N; Beary, Jonathan M; Newey, Christopher R 2018. Improvement in Sonographic Vasospasm Following Intravenous Milrinone in a Subarachnoid Hemorrhage Patient with Normal Cardiac Function. Cureus, 10 7, e2916

Katyal, Nakul; Narula, Naureen; George, Pravin; Nattanamai, Premkumar; Newey, Christopher R; Beary, Jonathan M 2018. Delayed Post-hypoxic Leukoencephalopathy: A Case Series and Review of the Literature. Cureus, 10 4, e2481

Katyal, Nakul; Newey, Christopher R; George, Pravin; Nattanamai, Premkumar; Beary, Jonathan M; Ardelt, Agnieszka; Vellipuram, Anantha 2018. Somatosensory Evoked Potentials as a Tool to Evaluate Brainstem Herniation in the Neuroscience Intensive Care Unit. Cureus, 10 4, e2443

Katyal, Nakul; Taqui, Ather M; Tepper, Deborah; Beary, Jonathan M; Newey, Christopher R 2018. Fulminant Herpes Simplex Virus Type I Encephalitis Despite Maximal Medical Therapy. Cureus, 10 4, e2467

Mullaguri, Naresh; Katyal, Nakul; Sarwal, Aarti; Beary, Jonathan M; George, Pravin; Karthikeyan, Naresh; Nattanamai, Premkumar; Newey, Christopher R 2017. Pitfall in Pupillometry: Exaggerated Ciliospinal Reflex in a Patient in Barbiturate Coma Mimicking a Nonreactive Pupil. Cureus, 9 12, e2004

McClung, M R; Zanchetta, J R; Racewicz, A; Roux, C; Benhamou, C-L; Man, Z; Eusebio, R A; Beary, J F; Burgio, D E; Matzkin, E; Boonen, S; Delmas, P 2013. Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 24 1, 293-9

Ste-Marie, Louis-Georges; Brown, Jacques P; Beary, John F; Matzkin, Ellen; Darbie, Lynn M; Burgio, David E; Racewicz, Artur J 2009. Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study. Clinical therapeutics, 31 2, 272-85

Delmas, Pierre D; McClung, Michael R; Zanchetta, José R; Racewicz, Artur; Roux, Christian; Benhamou, Claude-Laurent; Man, Zulema; Eusebio, Rachelle A; Beary, John F; Burgio, David E; Matzkin, Ellen; Boonen, Steven 2008. Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. Bone, 42 1, 36-42

Garnero, P; Aronstein, W S; Cohen, S B; Conaghan, P G; Cline, G A; Christiansen, C; Beary, J F; Meyer, J M; Bingham, C O 2008. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. Osteoarthritis and cartilage, 16 6, 660-6

Raynauld, J-P; Martel-Pelletier, J; Berthiaume, M-J; Abram, F; Choquette, D; Haraoui, B; Beary, J F; Cline, G A; Meyer, J M; Pelletier, J-P 2008. Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period. Annals of the rheumatic diseases, 67 5, 683-8

Krzeski, Piotr; Buckland-Wright, Chris; Bálint, Géza; Cline, Gary A; Stoner, Karen; Lyon, Robert; Beary, John; Aronstein, William S; Spector, Tim D 2007. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis research & therapy, 9 5, R109

Pelletier, Jean-Pierre; Raynauld, Jean-Pierre; Berthiaume, Marie-Josée; Abram, François; Choquette, Denis; Haraoui, Boulos; Beary, John F; Cline, Gary A; Meyer, Joan M; Martel-Pelletier, Johanne 2007. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study. Arthritis research & therapy, 9 4, R74

Beary, John F 2006. Food and Drug Administration centennial: recognizing the guardians of our drug supply. Arthritis and rheumatism, 54 10, 3374

Bingham, Clifton O; Buckland-Wright, J Chris; Garnero, Patrick; Cohen, Stanley B; Dougados, Maxime; Adami, Silvano; Clauw, Daniel J; Spector, Timothy D; Pelletier, Jean-Pierre; Raynauld, Jean-Pierre; Strand, Vibeke; Simon, Lee S; Meyer, Joan M; Cline, Gary A; Beary, John F 2006. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis and rheumatism, 54 11, 3494-507

Cline, G A; Meyer, J M; Stevens, R; Buckland-Wright, C; Peterfy, C; Beary, John F 2006. Comparison of fixed flexion, fluoroscopic semi-flexed and MTP radiographic methods for obtaining the minimum medial joint space width of the knee in longitudinal osteoarthritis trials. Osteoarthritis and cartilage, 14 Suppl A , A32-6

O'Connor, Annette M; McKean, James D; Beary, John H; Brockus, Susan L 2006. Prevalence of exposure to Salmonella spp in finishing swine marketed in Iowa. American journal of veterinary research, 67 5, 829-33

Raynauld, Jean-Pierre; Martel-Pelletier, Johanne; Berthiaume, Marie-Josée; Beaudoin, Gilles; Choquette, Denis; Haraoui, Boulos; Tannenbaum, Hyman; Meyer, Joan M; Beary, John F; Cline, Gary A; Pelletier, Jean-Pierre 2006. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis research & therapy, 8 1, R21

Spector, Tim D; Conaghan, Philip G; Buckland-Wright, J Christopher; Garnero, Patrick; Cline, Gary A; Beary, John F; Valent, David J; Meyer, Joan M 2005. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis research & therapy, 7 3, R625-33

Beary, J F 2001. Joint structure modification in osteoarthritis: development of SMOAD drugs. Current rheumatology reports, 3 6, 506-12

Beary, J F 1996. Pharmaceutical marketing has real and proven value. Characteristics of materials distributed by drug companies: four points of view. Journal of general internal medicine, 11 10, 635-6

Beary, J F 1995. Inappropriate drug prescribing. JAMA, 273 6, 455-6; author reply

Beary, J F 1994. The CERT concept: an industry perspective. Clinical pharmacology and therapeutics, 56 6 Pt 1, 693-7

Beary, J F; Eaton, C R; Wierenga, D E 1993. Basic research and the cost of health care. Science (New York, N.Y.), 262 5138, 1358

Beary, J F 1992. Pharmaceutical ads in journals. Annals of internal medicine, 117 7, 616; author reply 61

Beary, J F 1992. Chirality and drug development. Lancet (London, England), 339 8791, 495

Beary, J F; Cleveland, C B 1992. DPS--the PMA perspective. American pharmacy, NS32 5, 6, 8

Beary, J F; Eaton, C R 1992. Chirality and drug development. Science (New York, N.Y.), 257 5067, 145

Beary, J F 1990. New drug and biologic product approvals in 1989. Southern medical journal, 83 11, 1289-94

Beary, J F 1990. Geriatric medications in the pipeline. Health affairs (Project Hope), 9 3, 157-60

Beary, J F 1989. New drug approvals in 1988. Southern medical journal, 82 8, 995-8

Beary, J F 1986. The polygraph: does it really detect lies? American family physician, 33 3, 98, 100

Brett, A S; Phillips, M; Beary, J F 1986. Predictive power of the polygraph: can the "lie detector" really detect liars? Lancet (London, England), 1 8480, 544-7

White, K B; Beary, J F 1986. Illegible handwritten medical records. The New England journal of medicine, 314 6, 390-1

Beary, J F 1984. Strategic planning: military medicine in the eighties. Military medicine, 149 4, 181-3

Beary, J F; Walter, L J; Johns, J H 1984. Leading causes of death for active duty military personnel. Military medicine, 149 6, 316-7

D'Angelo, L J; Beary, J F; Stair, T 1984. Tetanus mimicking "pseudotetanus". Southern medical journal, 77 8, 1052-3

Armstrong, P C; Beary, J F 1983. Office of the Assistant Secretary of Defense for Health Affairs: a history. Military medicine, 148 8, 637-43

Beary, J F 1983. Federal medical chiefs on progress and planning. Department of Defense. Military medicine, 148 11, 857-63

Beary, J F 1983. Medical readiness DoD's main goal. U. S. medicine, 19 2, 9-12

Nazzaro, J T; Beary, J F 1983. Benefits of a computerized pharmacy. JAMA, 249 24, 3302-3

Beary, J F 1982. Federal Medical Chiefs on progress and plans. Department of defense. Military medicine, 147 11, 943-8

Beary, J F; Bisgard, J C; Armstrong, P C 1982. The Civilian-Military Contingency Hospital System. The New England journal of medicine, 306 12, 738-40

Beary, J; Gilbert, S 1981. Coping with the "bashful bladder" syndrome. Lancet (London, England), 1 8235, 1429-30

Kimberly, R P; Lockshin, M D; Sherman, R L; Beary, J F; Mouradian, J; Cheigh, J S 1981. "End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients. Medicine, 60 4, 277-87

Beary, J F 1979. Mercury in sperm whale meat. Science (New York, N.Y.), 206 4424, 1260

Beary, J F 1979. Gout: diagnosis and therapy. ONA journal, 6 8, 313-7

Beary, J F; Summer, W R; Bulkley, B H 1979. Postpartum acute myocardial infarction: a rare occurrence of uncertain etiology. The American journal of cardiology, 43 1, 158-61

Beary, J F 1978. Tobacco subsidies. The New England journal of medicine, 298 13, 749

Beary, J F 1978. Pediatric injury and the steel jaw trap. JAMA, 239 10, 931

Beary, J F 1977. Pseudoephedrine producing postural hypotension in a pilot. Aviation, space, and environmental medicine, 48 4, 369

Beary, J F; Fortuin, N J 1974. Practolol for sinus tachycardia in asthma. Annals of internal medicine, 81 3, 405

Benson, H; Beary, J F; Carol, M P 1974. The relaxation response. Psychiatry, 37 1, 37-46

Beary J.;Eaton C.;Copmann T.;Wierenga D. 12-20-1993. USA drug and biologic product approvals during 1992 Journal of Pharmaceutical Medicine, 3 2, 101-109

Beary J.;Siegfried J.;Tavares R. 10-14-1998. US drug and biologic approvals in 1997 Drug Development Research, 44 2-3, 114-129

Huseby J.;Anderson P.;Beary J. 08-22-1991. Confusion about Drug Names New England Journal of Medicine, 325 8, 588-589

Beary J.;Robillard L.;Woollett G.;Siegfried J.;White T.;Shriver D. 04-01-1997. U.S. drug and biological approvals in 1996 Drug Development Research, 40 4, 275-291

Beary J.;Duchaine C.;Rhein R. 04-01-1996. U.S. Drug and biologic approvals in 1994-1995 Drug Development Research, 37 4, 197-207

Beary J. 01-01-1994. In Reply: More Conflicts of Interest: Review Articles Sponsored by the Pharmaceutical Industry JAMA: The Journal of the American Medical Association, 272 16, 1254

Beary J.;Robert Eaton C.;Copmann T.;Wierenga D. 01-01-1994. U.S. drug and biologic product approvals during 1993 Drug Development Research, 32 3, 127-133

Beary J.;Angel J.;Liebman M.;Lexchin J.;Noble R.;Agzarian A.;Krinsky D.;Wilkes M.;Doblin B.;Shapiro M. 01-01-1992. Pharmaceutical ads in journals [1] Annals of Internal Medicine, 117 7, 616-619

Beary J.;Wierenga D.;Copmann T. 01-01-1992. USA drug and biological product approvals during 1990 Journal of Pharmaceutical Medicine, 2 1, 59-65

Beary J.;Wierenga D.;Copmann T.;Eaton C. 01-01-1992. USA drug and biologic product approvals during 1991 Journal of Pharmaceutical Medicine, 2 3, 175-182

Beary J. 01-01-1990. Directions in research for Alzheimer's treatments Hospital Pharmacy, 25 6, 593-594

Beary, J F; Benson, H . A simple psychophysiologic technique which elicits the hypometabolic changes of the relaxation response. Psychosomatic medicine, 36 2, 115-20